Pharmavite, FDA Offer Alternate Takes On GMP Compliance Strategy
This article was originally published in The Tan Sheet
Executive Summary
A Pharmavite executive outlined a “different perspective” from the conventional wisdom promoted by FDA on successful compliance with dietary supplement good manufacturing practices: an emphasis on finished product specifications.You may also be interested in...
GMP Qualification And Testing Provisions Still Trip Supplement Firms
A year after the final step in the three-year rollout of the dietary supplement good manufacturing practices final rule, firms large and small are learning the hard way what FDA expects to find in a facility.
FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
Some dietary supplement firms will not be ready to comply with good manufacturing practices by the rapidly approaching final deadline, according to a senior FDA advisor on supplement products
CBD Safety And Hemp Farming Have Equal Space In Rep. Harris’ Concerns
“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: